Skip to main content

Table 1 Frequency of mutations and/or gene amplification in anti-malarial resistance markers pfmdr1 and pfcrt in Plasmodium falciparum isolates in Yaoundé and Mfou, Cameroon

From: Molecular monitoring of plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: Implications for the future

Genes and alleles

Number of samples (%)

P

 

Both sites

Yaoundé

Mfou

(Suburb of Yaoundé)

 

pfmdr1 amplification (na = 215, nb = NA)

   1 pfmdr1 copy number

215

(100%)

215

(100%)

NA

NA

NA

   > 1 pfmdr1 copy number

0

(0%)

0

(0%)

NA

NA

 

pfmdr1 codon 86 (na = 201, nb = 209)

   Mutant 86Y haplotype only

328

(80%)

153

(76%)

175

(84%)

NS

   Mixed N86 and 86Y haplotypes

53

(13%)

28

(14%)

25

(12%)

 

   Wild-type N86 haplotype only

29

(7%)

20

(10%)

9

(4%)

 

   Total mutant 86Y haplotypec

381

(93%)

181

(90%)

200

(96%)

0.042 d

pf c rt codon 76 (na = 203, nb = 229)

   Mutant 76T haplotype only

270

(62%)

145

(71%)

125

(55%)

< 0.001e

   Mixed K76 and 76T haplotypes

89

(21%)

20

(10%)

69

(30%)

 

   Wild-type K76 haplotype only

73

(17%)

38

(19%)

35

(15%)

 

   Total mutant 76T haplotypec

359

(83%)

165

(81%)

194

(85%)

NS d

pf c rt codon 72 (na = 202, nb = 212)

   Mutant 72S haplotype

0

(0%)

0

(0%)

0

(0%)

NS

   Wild-type C72 haplotype

414

(100%)

202

(100%)

212

(100%)

 
  1. NA: not analysable because of the limited amount of DNA samples
  2. NS: non significant
  3. a: Number of total samples tested in the centre of Yaoundé
  4. b: Number of total samples tested in the suburb of Yaoundé
  5. c: Total mutant haplotype regroups single mutant haplotype and mixed haplotype, all samples with mixed genotype for the considered allele are classified in mutant group.
  6. d: comparison of total mutant haplotypes versus wild-type haplotypes
  7. e: comparison of mutant, wild-type and mixed haplotypes